278 related articles for article (PubMed ID: 28676589)
1. Association between Catechol-O-Methyltransferase Val158Met (158G/A) Polymorphism and Suicide Susceptibility: A Meta-analysis.
Sadeghiyeh T; Hosseini Biouki F; Mazaheri M; Zare-Shehneh M; Neamatzadeh H; Poursharif Z
J Res Health Sci; 2017 Jun; 17(2):e00383. PubMed ID: 28676589
[TBL] [Abstract][Full Text] [Related]
2. Catechol-O-methyltransferase Gene Polymorphism (Val158Met) and Development of Pre-eclampsia.
Taravati A; Tohidi F; Moniri M; Kamali K
Arch Med Res; 2017 Feb; 48(2):180-186. PubMed ID: 28625321
[TBL] [Abstract][Full Text] [Related]
3. Significant association of catechol-O-methyltransferase Val158Met polymorphism with bladder cancer instead of prostate and kidney cancer.
Chen Y; Yu X; Li T; Yan H; Mo Z
Int J Biol Markers; 2016 May; 31(2):e110-7. PubMed ID: 27055785
[TBL] [Abstract][Full Text] [Related]
4. The Association between COMT Val158Met Polymorphism and the Post-Traumatic Stress Disorder Risk: A Meta-Analysis.
Su M; Song Y
Neuropsychobiology; 2022; 81(2):156-170. PubMed ID: 34657037
[TBL] [Abstract][Full Text] [Related]
5. Association of Val158Met polymorphism in COMT gene with attention-deficit hyperactive disorder: An updated meta-analysis.
Kang P; Luo L; Peng X; Wang Y
Medicine (Baltimore); 2020 Nov; 99(48):e23400. PubMed ID: 33235119
[TBL] [Abstract][Full Text] [Related]
6. Catechol-O-methyltransferase 158G/A polymorphism and endometriosis/adenomyosis susceptibility: A meta-analysis in the Chinese population.
Li YW; Wang CX; Chen JS; Chen L; Zhang XQ; Hu Y; Niu XB; Pei DX; Liu XW; Bi YY
J Cancer Res Ther; 2018 Dec; 14(Supplement):S980-S984. PubMed ID: 30539833
[TBL] [Abstract][Full Text] [Related]
7. Catechol-O-methyltransferase gene Val158Met polymorphism and obsessive compulsive disorder susceptibility: a meta-analysis.
Kumar P; Rai V
Metab Brain Dis; 2020 Feb; 35(2):241-251. PubMed ID: 31879835
[TBL] [Abstract][Full Text] [Related]
8. Association between Catechol-O-methyltransferase rs4680 (G>A) polymorphism and lung cancer risk.
Tan X; Chen M
Diagn Pathol; 2014 Oct; 9():192. PubMed ID: 25280560
[TBL] [Abstract][Full Text] [Related]
9. COMT Val158Met polymorphism and Parkinson's disease risk: a pooled analysis in different populations.
Wang YC; Zou YB; Xiao J; Pan CD; Jiang SD; Zheng ZJ; Yan ZR; Tang KY; Tan LM; Tang MS
Neurol Res; 2019 Apr; 41(4):319-325. PubMed ID: 30644790
[TBL] [Abstract][Full Text] [Related]
10. Association between the COMT Val158Met polymorphism and fibromyalgia susceptibility and fibromyalgia impact questionnaire score: a meta-analysis.
Lee YH; Kim JH; Song GG
Rheumatol Int; 2015 Jan; 35(1):159-66. PubMed ID: 24951880
[TBL] [Abstract][Full Text] [Related]
11. Association of Catechol-O-Methyltransferase Gene rs4680 Polymorphism and Levodopa Induced Dyskinesia in Parkinson's Disease: A Meta-Analysis and Systematic Review.
Dwivedi A; Dwivedi N; Kumar A; Singh VK; Pathak A; Chaurasia RN; Mishra VN; Mohanty S; Joshi D
J Geriatr Psychiatry Neurol; 2023 Mar; 36(2):98-106. PubMed ID: 35603896
[TBL] [Abstract][Full Text] [Related]
12. No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.
Zou LW; Xu XJ; Liu T; Wang HY; Fan WJ; Wang XH; Zhang ZX; Zhai JX
Genet Test Mol Biomarkers; 2013 Jan; 17(1):78-84. PubMed ID: 23116175
[TBL] [Abstract][Full Text] [Related]
13. The association between COMT Val158Met gene polymorphism and antipsychotic-induced tardive dyskinesia risk.
Lv Z; Rong B; Tong X; Li X; Chen X; Wang X; Li Z
Int J Neurosci; 2016 Nov; 126(11):1044-50. PubMed ID: 26398367
[TBL] [Abstract][Full Text] [Related]
14. Catechol-O-methyltransferase Val158Met polymorphism and altered COMT gene expression in the prefrontal cortex of suicide brains.
Du L; Merali Z; Poulter MO; Palkovits M; Faludi G; Anisman H
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():178-83. PubMed ID: 24389396
[TBL] [Abstract][Full Text] [Related]
15. Catechol-O-Methyltransferase (COMT) Val158Met Polymorphism and Eating Disorders: Data From a New Biobank and Meta-Analysis of Previously Published Studies.
Collantoni E; Solmi M; Gallicchio D; Santonastaso P; Meneguzzo P; Carvalho AF; Stubbs B; Clementi M; Pinato C; Forzan M; Cassina M; Fontana F; Piva I; Siani R; Salvo P; Tenconi E; Veronese N; Correll CU; Favaro A
Eur Eat Disord Rev; 2017 Nov; 25(6):524-532. PubMed ID: 29057600
[TBL] [Abstract][Full Text] [Related]
16. The association between COMT Val158Met polymorphism and migraine risk: A meta-analysis.
Liao YJ; Jiang JR; Jin SQ
Cephalalgia; 2017 May; 37(6):592-598. PubMed ID: 27154995
[TBL] [Abstract][Full Text] [Related]
17. The associations between the Val158Met in the catechol-O-methyltransferase (COMT) gene and the risk of uterine leiomyoma (ULM).
Feng Y; Zhao X; Zhou C; Yang L; Liu Y; Bian C; Gou J; Lin X; Wang Z; Zhao X
Gene; 2013 Oct; 529(2):296-9. PubMed ID: 23939469
[TBL] [Abstract][Full Text] [Related]
18. Contribution of catechol-O-methyltransferase Val158Met polymorphism to endometrial cancer risk in postmenopausal women: a meta-analysis.
Lin G; Zhao J; Wu J; Andreevich O R; Zhang WH; Zhang Y; Yu L
Genet Mol Res; 2013 Dec; 12(4):6442-53. PubMed ID: 24390993
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility.
Zhang H; Zhang Z; Wu J; Xu Y; Cheng R; Li L
Urol Int; 2013; 91(2):213-9. PubMed ID: 23257985
[TBL] [Abstract][Full Text] [Related]
20. COMT Val158Met and PPARγ Pro12Ala polymorphisms and susceptibility to Alzheimer's disease: a meta-analysis.
Lee YH; Song GG
Neurol Sci; 2014 May; 35(5):643-51. PubMed ID: 24477323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
